Molecular diagnosis of sarcomas: Chromosomal translocations in sarcomas

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 8, 2006, Pages 1199-1207

  Lazar, Alexander ^a   Abruzzo, Lynne V ^a   Pollock, Raphael E ^a   Lee, Sangkyou ^a   Czerniak, Bogdan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

CHIMERA; CHROMOSOMAL KARYOTYPING; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CORRELATION ANALYSIS; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EWING SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; HEMATOXYLIN EOSINE STAIN; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; RARE DISEASE; REVIEW; SARCOMA; SPECTRAL KARYOTYPING; STAINING; SYNOVIAL SARCOMA; SYSTEMATIC REVIEW; VALIDATION PROCESS;

BONE NEOPLASMS; DNA, NEOPLASM; HUMANS; KARYOTYPING; MOLECULAR DIAGNOSTIC TECHNIQUES; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; SARCOMA; SARCOMA, EWING'S; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 33746691887     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Oliveira AM, Fletcher CD. Molecular prognostication for soft tissue sarcomas: are we ready yet? J Clin Oncol. 2004;22:4031-4034.
2. Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nat Rev Cancer. 2003;3:685-694.
3. Xia SJ, Barr FG. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors. Eur J Cancer. 2005;41:2513-2527.
4. Borden EC, Baker LH, Bell RS, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003;9:1941-1956.
5. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: synovial sarcoma. Cancer Genet Cytogenet. 2002;133:1-23.
6. Coindre JM, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L. Should molecular testing be required for diagnosing synovial sarcoma: a prospective study of 204 cases. Cancer. 2003;98:2700-2707.
7. Folpe AL, Goldblum JR, Rubin BP, et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol. 2005;29:1025-1033.
8. May WA, Gishizky ML, Lessnick SL, et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FL11 for transformation. Proc Natl Acad Sci U S A. 1993;90:5752-5756.
9. Aurias A, Rimbaut C, Buffe D, Zucker JM, Mazabraud A. Translocation involving chromosome 22 in Ewing's sarcoma: a cytogenetic study of four fresh tumors. Cancer Genet Cytogenet. 1984;12:21-25.
10. Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors: a sub-group of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med. 1994;331:294-299.
11. Pellin A, Boix J, Blesa JR, Noguera R, Carda C, Llombart-Bosch A. EWS/FLI-1 rearrangement in small round cell sarcomas of bone and soft tissue detected by reverse transcriptase polymerase chain reaction amplification. Eur J Cancer. 1994;30A:827-831.
12. Sandberg AA, Bridge JA. Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet. 2000;123:1-26.
13. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet. 1994;6:146-151.
14. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359:162-165.
15. Bhagirath T, Abe S, Nojima T, Yoshida MC. Molecular analysis of a t(11; 22) translocation junction in a case of Ewing's sarcoma. Genes Chromosomes Cancer. 1995;13:126-132.
16. Khoury JD. Ewing sarcoma family of tumors. Adv Anat Pathol. 2005;12:212-220.
17. Prasad DD, Rao VN, Reddy ES. Structure and expression of human Fli-1 gene. Cancer Res. 1992;52:5833-5837.
18. Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5:908-918.
19. Dardick I, Ramjohn S, Thomas MJ, Jeans D, Hammar SP. Synovial sarcoma: inter-relationship of the biphasic and monophasic subtypes. Pathol Res Pract. 1991;187:871-885.
20. Fisher C. Synovial sarcoma: ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors. Hum Pathol. 1986;17:996-1008.
21. Krall RA, Kostianovsky M, Patchefsky AS. Synovial sarcoma: a clinical, pathological, and ultrastructural study of 26 cases supporting the recognition of a monophasic variant. Am J Surg Pathol. 1981;5:137-151.
22. Varela-Duran J, Enzinger FM. Calcifying synovial sarcoma. Cancer. 1982; 50:345-352.
23. de Leeuw B, Berger W, Sinke RJ, et al. Identification of a yeast artificial chromosome (YAC) spanning the synovial sarcoma-specific t(X;18)(p11.2;q11.2) breakpoint. Genes Chromosomes Cancer. 1993;6:182-189.
24. Limon J, Mrozek K, Mandahl N, et al. Cytogenetics of synovial sarcoma: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer. 1991;3:338-345.
25. Kasai T, Shimajiri S, Hashimoto H. Detection of SYT-SSX fusion transcripts in both epithelial and spindle cell areas of biphasic synovial sarcoma using laser capture microdissection. Mol Pathol. 2000;53:107-110.
26. Knight JC, Reeves BR, Kearney L, Monaco AP, Lehrach H, Cooper CS. Localization of the synovial sarcoma t(X;18)(p11.2;q11.2) breakpoint by fluorescence in situ hybridization. Hum Mol Genet. 1992;1:633-637.
27. Ladanyi M. Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene. 2001;20:5755-5762.
28. Brodin B, Haslam K, Yang K, et al. Cloning and characterization of spliced fusion transcript variants of synovial sarcoma; SYT/SSX4, SYT/SSX4v, and SYT/SSX2v: possible regulatory role of the fusion gene product in wild type SYT expression. Gene. 2001;268:173-182.
29. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62:135-140.
30. Mezzelani A, Mariani L, Tamborini E, et al. SYT-SSX fusion genes and prognosis in synovial sarcoma. Br J Cancer. 2001;85:1535-1539.
31. Guillou L, Benhattar J, Bonichon F, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004;22:4040-4050.
32. Ladanyi M. Correlates of SYT-SSX fusion type in synovial sarcoma: getting more complex but also more interesting? J Clin Oncol. 2005;23:3638-3639; author reply 3639-3640.
33. Antonescu CR, Kawai A, Leung DH, et al. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol. 2000;9:1-8.